Median Number of HAE Attacks/Month
Study Design A 32-week crossover study with patients ≥12 years of age with symptomatic type 1 or 2 HAE (N=90).1
The WAO Guideline for the Management of HAE states that patients should have HAE rescue medication available at all times2
*Median reduction in number of attacks in patients receiving 60 IU/kg of HAEGARDA vs placebo.
†Median reduction in rescue medication use in patients receiving 60 IU/kg of HAEGARDA vs placebo.
‡Median attack rate in patients followed over an average of 1.5 years.